Cancer4 March 2026· 8 min read
NHS expands abiraterone access for high-risk prostate
NHS England has widened abiraterone acetate access for adults with high-risk non-metastatic prostate cancer, with treatment expected to reach eligible patients within weeks. The change matters because
By Tom Okafor, Clinical Trials Correspondent
Cancer31 July 2025· 8 min read
CAR T‑cell Therapy Revolutionises Cancer Treatment
The idea that a single infusion of a patient's own immune cells could clear aggressive cancer once seemed like daring fiction. CAR T‑cell therapy has turned that notion into clinical fact, standing sh
By Dr. Eleanor Vance, Regulatory Affairs Editor
Cancer15 May 2025· 10 min read
KAIST's Breakthrough: Reprogramming Colon Cancer Cells to Behave Normally
In the long and often punishing battle against cancer, modern medicine has relied heavily on eradication: cut, burn, poison — remove the disease before it removes the patient. While effective in many
By Dr. Eleanor Vance, Regulatory Affairs Editor
Cancer21 March 2025· 13 min read
Discover how aspirin could revolutionise cancer prevention today
Cancer remains one of the most serious health challenges in the world, with millions of people affected by various forms of the disease each year. In recent years, however, a simple over-the-counter m
By Tom Okafor, Clinical Trials Correspondent
Cancer16 March 2023· 3 min read
Advancements in Clinical Trials for Lymphoma Cancer Patients
Lymphoma cancer is a type of cancer that affects the lymphatic system, which is responsible for fighting infections and diseases. While there are several types of lymphoma, the two main categories are
By Tom Okafor, Clinical Trials Correspondent
Cancer15 February 2023· 3 min read
Cervical Cancer: Northern Ireland Urged to Adopt HPV Testing
Cervical cancer is one of the main reasons women die, but it can be stopped if it is found and treated early. In recent years, much progress has been made in the fight against cervical cancer, with th
By Tom Okafor, Clinical Trials Correspondent
Cancer8 January 2023· 3 min read
Clinical trial for the cancer mRNA vaccine has over
Years of preclinical and clinical trials on mRNA vaccines for cancer therapy have laid the groundwork for making mRNA vaccines during the COVID-19 pandemic. The inherent benefit of ease of production,
By Tom Okafor, Clinical Trials Correspondent